Related Articles

News
STAT+: Up and down the ladder: The latest comings and goings
April 1, 2022
San Francisco Biotechnology Network News
News
Comments Off on STAT+: Up and down the ladder: The latest comings and goings
From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry. […]

News
Listen: The anti-aging research boom, the Godfather of biotech, & the future of Biogen
September 1, 2022
San Francisco Biotechnology Network News
News
Comments Off on Listen: The anti-aging research boom, the Godfather of biotech, & the future of Biogen
What can worms teach us about immortality? How does one become the Godfather? And where does Biogen go from here? Find out on the new episode of “The Readout LOUD”… […]

News
STAT+: Bristol Myers agrees to settle lawsuit alleging anti-competitive deals involving HIV drugs
April 14, 2022
San Francisco Biotechnology Network News
News
Comments Off on STAT+: Bristol Myers agrees to settle lawsuit alleging anti-competitive deals involving HIV drugs
Bristol Myers Squibb has agreed to pay up to $11 million to settle a lawsuit that accused several drugmakers of conspiring to block generic competition to HIV medicines. […]